Related Experiment Video
Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2 and MDMX: Alone and together in regulation of p53
Miriam Shadfan1, Vanessa Lopez-Pajares, Zhi-Min Yuan
1Department of Cellular and Structural Biology and Department of Radiation Oncology, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Abstract:
p53, a critical tumor suppressor, is activated by various cellular stresses to prevent and repair damages that can lead to tumor development. In response to these stresses, p53 activation can cause very serious cellular effects including permanent cell cycle arrest and cell death. p53 must therefore be very tightly regulated to avoid unnecessary pathological effects. The homologs MDM2 and MDMX have been shown to be the major, essential negative regulators of p53. In normal cells, MDM2 and MDMX suppress p53 activity, but in the event of cellular stress, they themselves must be inhibited so that p53 may respond to the stress. MDM2 and MDMX are known to bind together, and play multifaceted, non-redundant roles in modulating p53 protein activity. Recently, evidence has emerged showing that MDM2 and MDMX most effectively inhibit p53 as a complex, and possibly play non-redundant roles because they must function as one to control p53. In this review, we give an overview of MDM2 and MDMX and discuss a few ways in which they are modified so that p53 may be activated. Lastly, we discuss the non-redundant roles of MDM2 and MDMX and how it is important to investigate the effect on the complex as a whole when investigating either protein.
Insights
The tumor suppressor p53 is regulated by MDM2 and MDMX. These proteins form a complex to inhibit p53, and understanding this interaction is key to cancer research.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- p53 is a critical tumor suppressor that halts cell cycle progression or induces apoptosis in response to cellular stress.
- MDM2 and MDMX are the primary negative regulators of p53, suppressing its activity in normal cells.
- Dysregulation of p53 activity is a hallmark of many cancers.
Purpose of the Study:
- To provide an overview of MDM2 and MDMX, the key negative regulators of p53.
- To discuss the mechanisms by which MDM2 and MDMX are modified to allow p53 activation.
- To explore the non-redundant roles of MDM2 and MDMX in p53 regulation.
Main Methods:
- Literature review of existing studies on p53, MDM2, and MDMX.
- Analysis of the interaction and complex formation between MDM2 and MDMX.
- Discussion of post-translational modifications affecting MDM2 and MDMX function.
Main Results:
- MDM2 and MDMX form a complex that is essential for the effective inhibition of p53.
- MDM2 and MDMX play multifaceted and non-redundant roles in modulating p53 activity.
- Modifications to MDM2 and MDMX are crucial for p53 activation in response to cellular stress.
Conclusions:
- The MDM2-MDMX complex is the primary functional unit for p53 inhibition.
- Investigating MDM2 and MDMX requires consideration of their complex as a whole.
- Understanding the regulation of the MDM2-MDMX complex is vital for therapeutic strategies targeting p53.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators

